BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21203448)

  • 1. Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors.
    Annamalai L; Westmoreland SV; Domingues HG; Walsh DG; Gonzalez RG; O'Neil SP
    PLoS One; 2010 Dec; 5(12):e14429. PubMed ID: 21203448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.
    Annamalai L; Bhaskar V; Pauley DR; Knight H; Williams K; Lentz M; Ratai E; Westmoreland SV; González RG; O'Neil SP
    Am J Pathol; 2010 Aug; 177(2):777-91. PubMed ID: 20595631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS.
    Walker JA; Beck GA; Campbell JH; Miller AD; Burdo TH; Williams KC
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26185285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
    Metzner KJ; Binley JM; Gettie A; Marx P; Nixon DF; Connor RI
    Retrovirology; 2006 Dec; 3():97. PubMed ID: 17184540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis.
    Walker JA; Sulciner ML; Nowicki KD; Miller AD; Burdo TH; Williams KC
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):685-94. PubMed ID: 24524407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment.
    Spring M; Stahl-Hennig C; Stolte N; Bischofberger N; Heeney J; ten Haaft P ; Tenner-Ràcz K; Ràcz P; Lorenzen D; Hunsmann G; Dittmer U
    Virology; 2001 Jan; 279(1):221-32. PubMed ID: 11145904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy.
    González RG; Greco JB; He J; Lentz MR; O'Neil S; Pilkenton SJ; Ratai EM; Westmoreland S
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):152-9. PubMed ID: 18040781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
    Murphey-Corb M; Rajakumar P; Michael H; Nyaundi J; Didier PJ; Reeve AB; Mitsuya H; Sarafianos SG; Parniak MA
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4707-12. PubMed ID: 22713337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.
    Clements JE; Li M; Gama L; Bullock B; Carruth LM; Mankowski JL; Zink MC
    J Neurovirol; 2005 Apr; 11(2):180-9. PubMed ID: 16036796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal trajectories of brain volume in combined antiretroviral therapy treated and untreated simian immunodeficiency virus-infected rhesus macaques.
    Liu D; Liu J; Xu T; Qiao H; Qi Y; Gao Y; Ailixire ; Gao L; Li C; Xia M; Li H
    AIDS; 2021 Dec; 35(15):2433-2443. PubMed ID: 34870927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    Del Prete GQ; Smedley J; Macallister R; Jones GS; Li B; Hattersley J; Zheng J; Piatak M; Keele BF; Hesselgesser J; Geleziunas R; Lifson JD
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):163-8. PubMed ID: 26150024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.
    Perez S; Johnson AM; Xiang SH; Li J; Foley BT; Doyle-Meyers L; Panganiban A; Kaur A; Veazey RS; Wu Y; Ling B
    J Neurovirol; 2018 Feb; 24(1):62-74. PubMed ID: 29181724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
    Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination antiretroviral therapy on Chinese rhesus macaques of simian immunodeficiency virus infection.
    Ling B; Rogers L; Johnson AM; Piatak M; Lifson J; Veazey RS
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1465-74. PubMed ID: 23387294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses.
    Graham DR; Gama L; Queen SE; Li M; Brice AK; Kelly KM; Mankowski JL; Clements JE; Zink MC
    J Neurovirol; 2011 Feb; 17(1):120-30. PubMed ID: 21165785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
    Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
    J Virol; 2018 May; 92(9):. PubMed ID: 29467313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
    PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.